PDLI

PDL BioPharma, Inc.
PDLI

Overview Fund Activity
Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

148 hedge funds and large institutions have $332M invested in PDL BioPharma, Inc. in 2019 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 38 increasing their positions, 64 reducing their positions, and 20 closing their positions.

Holders
148
Holders Change
-9
Holders Change %
-5.73%
% of All Funds
3.22%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
38
Reduced
64
Closed
20
Calls
$356K
Puts
$38K
Net Calls
+$318K
Net Calls Change
-$20K

Top Buyers

1
Nuveen Asset Management
1
Nuveen Asset Management
Illinois
$1.74M
2
Citadel Advisors
2
Citadel Advisors
Florida
$9.44M
3
Marshall Wace
3
Marshall Wace
United Kingdom
$1.56M
4
State Street
4
State Street
Massachusetts
$21.4M
5
CEP
5
Chicago Equity Partners
Illinois
$1.72M

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$29.3M
2
BlackRock
2
BlackRock
New York
$34.7M
3
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$34.7M
4
Bank of America
4
Bank of America
North Carolina
$1.09M
5
Morgan Stanley
5
Morgan Stanley
New York
$1.33M
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$34.7M 11,054,490 -1,294,598 -10%
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$34.7M 11,047,261 -996,145 -8%
Vanguard Group
3
Vanguard Group
Pennsylvania
$29.3M 9,326,891 -1,304,470 -12%
Renaissance Technologies
4
Renaissance Technologies
New York
$28.3M 9,021,082 -607,418 -6%
State Street
5
State Street
Massachusetts
$21.4M 6,820,171 +450,299 +7%
Northern Trust
6
Northern Trust
Illinois
$14.6M 4,635,205 -53,749 -1%
Connor, Clark & Lunn Investment Management (CC&L)
7
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$14.1M 4,487,584 -503,889 -10%
BIP
8
Brandes Investment Partners
California
$13.1M 4,171,971 -173,112 -4%
Charles Schwab
9
Charles Schwab
California
$11.5M 3,674,141 +204,999 +6%
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$9.94M 3,164,073 +68,931 +2%
Citadel Advisors
11
Citadel Advisors
Florida
$9.44M 3,007,552 +500,817 +20%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$6.13M 1,950,448 -59,001 -3%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$6.11M 1,946,492 -78,243 -4%
Arrowstreet Capital
14
Arrowstreet Capital
Massachusetts
$5.73M 1,825,381 -748,902 -29%
AQR Capital Management
15
AQR Capital Management
Connecticut
$5.46M 1,739,713 -637,341 -27%
Grantham, Mayo, Van Otterloo & Co (GMO)
16
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$5.27M 1,678,900 -4,900 -0.3%
WG
17
Winton Group
United Kingdom
$4.36M 1,386,885 +51,942 +4%
Fuller & Thaler Asset Management
18
Fuller & Thaler Asset Management
California
$3.9M 1,243,125 -6,915 -0.6%
BCM
19
Bridgeway Capital Management
Texas
$3.05M 971,800 – –
Invesco
20
Invesco
Georgia
$3.03M 965,447 -281,596 -23%
Nomura Holdings
21
Nomura Holdings
Japan
$2.99M 976,011 +26,525 +3%
UBS Group
22
UBS Group
Switzerland
$2.98M 949,456 +117,036 +14%
PPA
23
Parametric Portfolio Associates
Washington
$2.81M 894,675 -239,776 -21%
Wells Fargo
24
Wells Fargo
California
$2.27M 722,596 +382,397 +112%
OAM
25
Oxford Asset Management
United Kingdom
$2.15M 683,610 -384,068 -36%
1
2 3 4 5